Cart
sales@molnova.com
SACLAC
CAS No. 2248703-42-4
SACLAC( —— )
Catalog No. M37347 CAS No. 2248703-42-4
SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | In Stock |
|
| 5MG | 459 | In Stock |
|
| 10MG | 657 | In Stock |
|
| 25MG | 994 | In Stock |
|
| 50MG | 1371 | In Stock |
|
| 100MG | 1773 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSACLAC
-
NoteResearch use only, not for human use.
-
Brief DescriptionSACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
-
DescriptionSACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | Caspase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2248703-42-4
-
Formula Weight377.99
-
Molecular FormulaC20H40ClNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H]([C@@H](CCCCCCCCCCCCCCC)O)(NC(CCl)=O)CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
1-[2,4-Dihydroxy-6-m...
Xanthohumol, prenylchacone flavonoid, is a natural product with multi-biofunctions purified from Hops Humulus lupulus. Xanthohumol is effective against HIV-1 and might serve as an interesting lead compound. It may represent a novel chemotherapeutic agent for HIV-1 infection.
-
MKC-1
MKC-1 is an orally bioavailable, small-molecule, bisindolylmaleimide cell cycle inhibitor with potential antineoplastic activity. MKC-1 and its metabolites inhibit tubulin polymerization, blocking the formation of the mitotic spindle.
-
Pladienolide B
Pladienolide B is a potent spliceosome inhibitor, a macrolide isolated from Streptomyces obtusususus Mer-12, which targets the SF3B1 subunit of the spliceosome.
